Compounds > satavaptan
Page last updated: 2024-09-04

satavaptan and End Stage Liver Disease

satavaptan has been researched along with End Stage Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aagaard, NK; Gantzel, RH; Grønbaek, H; Jepsen, P; Vilstrup, H; Watson, H1

Trials

1 trial(s) available for satavaptan and End Stage Liver Disease

ArticleYear
Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality.
    Hepatology communications, 2022, Volume: 6, Issue:11

    Topics: Ascites; Diuretics; End Stage Liver Disease; Humans; Liver Cirrhosis; Patient Reported Outcome Measures; Severity of Illness Index; Sodium

2022